Regional bone, muscle and joint congress to open in Abu Dhabi

December 04, 2015

December 4, 2015 - Abu Dhabi, UAE

The doors of the Abu Dhabi National Exhibition Centre (ADNEC) will open on December 5th to leading musculoskeletal disease researchers and a wide range of health professionals who treat patients with osteoporosis and related diseases.

The more than 800 delegates attending the IOF Regionals 3rd Middle East and Africa Osteoporosis Meeting will hear about the latest research and learn about new advances in prevention and diagnosis, osteoporosis management, secondary fracture prevention and bone care for diabetics. The Meeting is officially endorsed by Health Authority Abu Dhabi (HAAD) and the Abu Dhabi Health Services (SEHA).

An audit report issued in 2011 by IOF in cooperation with national osteoporosis societies from 17 countries in the region showed that osteoporosis is a serious and growing problem throughout the Middle East and parts of Africa. This is due to the predicted demographic explosion in the number of people over the age of 50 in the coming decades. By 2050 it is expected that 40% of the population in the region will be over the age of 50, resulting in a surge in the number of fragility fractures and related disability. In several countries, including Lebanon and Jordan, the number of hip fractures is projected to quadruple.

"Osteoporosis, which can result in painful and highly debilitating fractures, is a significant cause of disability and early mortality in the older population," said IOF President Professor John A. Kanis. We hope that the new research findings and clinical advances presented at this congress will give delegates valuable insights for improved patient care and the targeted prevention of first and secondary fractures - including in diabetic patients."

As the region's largest event in the field, the Meeting will feature more than 60 sessions, with a wide range of educational lectures and workshops. The Meeting has been designated for 18 European and 18.5 Health Authority Abu Dhabi Continuing Medical Education credits.

At the opening of the Congress the delegates will be welcomed by Honorary Guest Speaker, Dr Mugheer Al Khialy, Chairman of Abu Dhabi Health Authority. Also speaking at the opening will be Prof. Abdulrahim Al Suhaili, Meeting Co-chair and President of the Emirates Osteoporosis Society (EOS); Dr Madhat Khafajy, Co-chair of the Scientific Programme Committee; Prof. Serge Ferrari, Co-chair of the Scientific Programme Committee; Prof. John A Kanis, President of IOF.

A unique feature of the Meeting will be the 'Bone and Diabetes' Pre-Meeting Workshop which tackles an issue of growing importance in the Middle East where diabetes is highly prevalent. Dr Maha Barakat, CEO of HAAD will be chairing the Workshop and giving a lecture. The relationship between diabetes and osteoporosis has, until recently, suffered from a general lack of attention and research. As a result, health professionals who treat patients with diabetes often do not recognize that fragility fractures are a major complication of the disease. The Workshop will help to raise awareness among participants by presenting the latest knowledge on the mechanisms, evaluation and management of bone fragility in diabetics.

Another special feature of the Meeting is the presentation of the prestigious IOF Young Investigator Awards to the five researchers under the age of 40 who have submitted the five highest ranking abstracts to the meeting. The investigators are also invited to attend a unique half-day mentoring programme where leading experts provide valuable feedback and interact one-on-one with the young researchers.

As President of EOS, Dr Abdulrahim Al Suhaili stressed the importance of the upcoming event as a key research and educational forum for doctors in the region. He stated, "Although it has a growing impact on the health and quality of life of our older population, osteoporosis is not adequately addressed during medical training in most countries. I hope that this Meeting will serve to advance health professional education and foster new interest in bone research within the region."

The abstracts submitted to the meeting will be published in a supplement issue of the journal Osteoporosis International.
-end-
IOF Regionals 3rd Middle East & Africa Osteoporosis Meeting: Organized by the International Osteoporosis Foundation (IOF) in Abu Dhabi from December 5-7, 2015, the IOF Regionals is one of the largest medical and research events dedicated to osteoporosis and related diseases in the region. http://www.iofbonehealth.org/abudhabi-2015

International Osteoporosis Foundation: The International Osteoporosis Foundation (IOF) is a not-for-profit, nongovernmental organization dedicated to the worldwide fight against osteoporosis and related musculoskeletal diseases. IOF's members - scientific researchers, patient, medical and research societies and industry representatives from around the world - share a common vision of a world without osteoporotic fractures. IOF, with headquarters in Switzerland, currently includes 232 member societies in 98 countries, regions and territories. Among its numerous programmes and activities, IOF mobilizes the global osteoporosis movement on World Osteoporosis Day, marked on October 20 every year. http://www.iofbonehealth.org; http://www.facebook.com/iofbonehealth;http://twitter.com/iofbonehealth

International Osteoporosis Foundation

Related Diabetes Articles from Brightsurf:

New diabetes medication reduced heart event risk in those with diabetes and kidney disease
Sotagliflozin - a type of medication known as an SGLT2 inhibitor primarily prescribed for Type 2 diabetes - reduces the risk of adverse cardiovascular events for patients with diabetes and kidney disease.

Diabetes drug boosts survival in patients with type 2 diabetes and COVID-19 pneumonia
Sitagliptin, a drug to lower blood sugar in type 2 diabetes, also improves survival in diabetic patients hospitalized with COVID-19, suggests a multicenter observational study in Italy.

Making sense of diabetes
Throughout her 38-year nursing career, Laurel Despins has progressed from a bedside nurse to a clinical nurse specialist and has worked in medical, surgical and cardiac intensive care units.

Helping teens with type 1 diabetes improve diabetes control with MyDiaText
Adolescence is a difficult period of development, made more complex for those with Type 1 diabetes mellitus (T1DM).

Diabetes-in-a-dish model uncovers new insights into the cause of type 2 diabetes
Researchers have developed a novel 'disease-in-a-dish' model to study the basic molecular factors that lead to the development of type 2 diabetes, uncovering the potential existence of major signaling defects both inside and outside of the classical insulin signaling cascade, and providing new perspectives on the mechanisms behind insulin resistance in type 2 diabetes and possibly opportunities for the development of novel therapeutics for the disease.

Tele-diabetes to manage new-onset diabetes during COVID-19 pandemic
Two new case studies highlight the use of tele-diabetes to manage new-onset type 1 diabetes in an adult and an infant during the COVID-19 pandemic.

Genetic profile may predict type 2 diabetes risk among women with gestational diabetes
Women who go on to develop type 2 diabetes after having gestational, or pregnancy-related, diabetes are more likely to have particular genetic profiles, suggests an analysis by researchers at the National Institutes of Health and other institutions.

Maternal gestational diabetes linked to diabetes in children
Children and youth of mothers who had gestational diabetes during pregnancy are at increased risk of diabetes themselves, according to new research published in CMAJ (Canadian Medical Association Journal).

Two diabetes medications don't slow progression of type 2 diabetes in youth
In youth with impaired glucose tolerance or recent-onset type 2 diabetes, neither initial treatment with long-acting insulin followed by the drug metformin, nor metformin alone preserved the body's ability to make insulin, according to results published online June 25 in Diabetes Care.

People with diabetes visit the dentist less frequently despite link between diabetes, oral health
Adults with diabetes are less likely to visit the dentist than people with prediabetes or without diabetes, finds a new study led by researchers at NYU Rory Meyers College of Nursing and East Carolina University's Brody School of Medicine.

Read More: Diabetes News and Diabetes Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.